/CBDL

CBDL Stock - CBD Life Sciences Inc.

Q: What is the analyst price target for CBDL?

Analyst price target information is not currently available for CBDL.

Q: What is CBDL's market cap?

Market capitalization information is not currently available for CBDL.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for CBDL

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-3603.52

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$108,891	$167,147	$160,241	$59,257	$225,897
Gross Profit	$-9,890	$-30,602	$-280,260	$-148,249	$-212,230
Gross Margin	-9.1%	-18.3%	-174.9%	-250.2%	-93.9%
Operating Income	$-757,189	$-78,574	$-859,800	$-5,128,240	$-384,090
Net Income	$-757,189	$-78,574	$-859,804	$-5,128,242	$-1,694,396
Net Margin	-695.4%	-47.0%	-536.6%	-8654.2%	-750.1%
EPS	$-0.00	$-0.00	$-0.00	$-0.00	$-0.00

Company Overview

CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.

Visit Website

Frequently Asked Questions about CBDL

What is CBDL's current stock price?

CBD Life Sciences Inc. (CBDL) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for CBDL?

No analyst price targets are currently available for this stock.

What sector is CBD Life Sciences Inc. in?

CBD Life Sciences Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is CBDL's market cap?

CBD Life Sciences Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does CBDL pay dividends?

No, CBD Life Sciences Inc. does not currently pay a dividend to shareholders.